ES2175184T3 - Virus que expresan proteinas toxicas y leneas celulares productoras. - Google Patents

Virus que expresan proteinas toxicas y leneas celulares productoras.

Info

Publication number
ES2175184T3
ES2175184T3 ES96945414T ES96945414T ES2175184T3 ES 2175184 T3 ES2175184 T3 ES 2175184T3 ES 96945414 T ES96945414 T ES 96945414T ES 96945414 T ES96945414 T ES 96945414T ES 2175184 T3 ES2175184 T3 ES 2175184T3
Authority
ES
Spain
Prior art keywords
viruses
toxic proteins
producing cellular
cellular lines
express toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96945414T
Other languages
English (en)
Inventor
Sunil Chada
Nicholas J Depolo
Sybille Sauter
Joan Robbins
Douglas J Jolly
William C Manning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ES2175184T3 publication Critical patent/ES2175184T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/10—Vectors comprising a special translation-regulating system regulates levels of translation
    • C12N2840/105—Vectors comprising a special translation-regulating system regulates levels of translation enhancing translation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBEN VECTORES DE EXPRESION QUE PRESENTAN UN PROMOTOR FUERTEMENTE CONTROLABLE, QUE DIRIGE LA EXPRESION DE UNA PROTEINA FUSOGENICA. TAMBIEN SE DESCRIBEN MOLECULAS DE ACIDOS NUCLEICOS QUE CODIFICAN TOXICOS DE PROTEINAS FUSOGENICAS, ESTANDO ALTERADOS UNO O MAS RESTOS CISTEINA DE LA MOLECULA DEL ACIDO NUCLEICO PARA PRODUCIR UN CODON DE TERMINACION OPALO.
ES96945414T 1995-12-29 1996-12-20 Virus que expresan proteinas toxicas y leneas celulares productoras. Expired - Lifetime ES2175184T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58055495A 1995-12-29 1995-12-29
US58055695A 1995-12-29 1995-12-29

Publications (1)

Publication Number Publication Date
ES2175184T3 true ES2175184T3 (es) 2002-11-16

Family

ID=27078078

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96945414T Expired - Lifetime ES2175184T3 (es) 1995-12-29 1996-12-20 Virus que expresan proteinas toxicas y leneas celulares productoras.

Country Status (8)

Country Link
EP (1) EP0870050B1 (es)
JP (1) JP2000502261A (es)
AT (1) ATE219521T1 (es)
DE (1) DE69621949T2 (es)
DK (1) DK0870050T3 (es)
ES (1) ES2175184T3 (es)
PT (1) PT870050E (es)
WO (1) WO1997024452A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2337520B (en) * 1998-05-22 2000-06-14 Oxford Biomedica Ltd Delivery system
KR20010079671A (ko) * 1998-08-20 2001-08-22 스티븐 에이. 서윈. 엠.디. 재조합 유전자 생성물을 생성시키는 동안 세포독성을조절하는 억제 ｔＲＮＡ의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors

Also Published As

Publication number Publication date
DK0870050T3 (da) 2002-07-15
DE69621949T2 (de) 2002-09-26
EP0870050B1 (en) 2002-06-19
ATE219521T1 (de) 2002-07-15
WO1997024452A3 (en) 1997-11-06
EP0870050A2 (en) 1998-10-14
DE69621949D1 (de) 2002-08-01
PT870050E (pt) 2002-10-31
JP2000502261A (ja) 2000-02-29
WO1997024452A2 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
NZ316787A (en) Methods and compositions for the selective modification of nucleic acids
ATE188740T1 (de) Viruspartikel mit veraendertem wirtspektrum
DK0757717T3 (da) Papillomavirusvacciner
DK0770679T3 (da) HCV-specifikke peptider, præparater indeholdende dem og anvendelse deraf
BR9509001A (pt) Proteína que objetiva virions de HIV com base em moléculas de fusão HIV-1 VPR
PT698216E (pt) Metodos de tipificacao do virus da hepatite c e reagentes para utilizar nestes
PT742821E (pt) Processo de preparacao de uma biblioteca multicombinatoria de vectores de expressao de genes de anticorpos
HUP0000318A2 (hu) Tumorvakcina és eljárás előállítására
EP1012603A4 (en) FUNCTIONAL FRAGMENTS OF THE HIV-1 VPR PROTEIN AND METHODS OF USE
ATE273388T1 (de) Veränderte menschliche c3-proteine
ES2232860T3 (es) Proteinas recombinantes de ribonucleasa.
BR0015287A (pt) Moléculas recombinantes de fusão
EP0749312A4 (en) DIROFILARIA IMMITIS - Gp29 - PROTEINS, NUCLEIC ACID MOLECULES AND THEIR USE
ES2175184T3 (es) Virus que expresan proteinas toxicas y leneas celulares productoras.
DK0941252T3 (da) Enkeltkædede anti-P53-antistoffragmenter og anvendelse heraf
ES2073451T3 (es) Vectores de clonacion y de expresion en una cepa de actinomiceto, procedimiento de transformacion de dicha cepa, cepa de actinomiceto obtenida y preparacion de proteinas.
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
ATE301721T1 (de) In vivo herstellung von replicativen molekülen
DE69533905D1 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
HUP0104254A2 (hu) Ezrin szabályozó/kihajtogató peptidek
EP0846165A4 (en) NOVEL PROTEINS AND NUCLEIC ACID MOLECULES OF FILARIID NEMATODE CYSTEIN PROTEASE AND THEIR USE
DE69726602D1 (en) Hepatitis b inhibitoren
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
AU1275095A (en) Antiviral composition of viral protein trans-dominant variants

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 870050

Country of ref document: ES